1
Gary G Liversidge, Elaine Liversidge, Pramod P Sarpotdar: Surface modified anticancer nanoparticles. Eastman Kodak Company, Arthur H Rosenstein, March 21, 1995: US05399363 (279 worldwide citation)

Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the particles exhibit reduced ...


2
Gary G Liversidge, Elaine Liversidge, Pramod P Sarpotdar: Surface modified anticancer nanoparticles. Eastman Kodak Company, Arthur H Rosenstein, February 27, 1996: US05494683 (105 worldwide citation)

Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the particles exhibit reduced ...


3
Liversidge Gary G C O Sterling, Liversidge Elaine C O Sterling, Sarpotdar Pramod C O Sterling: Surface modified anticancer nanoparticles.. Sterling Winthrop, January 5, 1994: EP0577215-A1 (74 worldwide citation)

Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the particles exhibit reduced ...


4
Gerald W Fischer, Luke T Daum: Immunogenic compositions and methods. Longhorn Vaccines and Diagnostics, Remenick PLLC, October 3, 2017: US09777045

Disclosed are immunogenic compositions and methods for their use in the formulation and administration of therapeutic and prophylactic pharmaceutical agents. In particular, the invention provides immunogenic compositions and methods for preventing, treating, and/or ameliorating the symptoms of one o ...


5
Niels P Ryde, Peter Snyder, Wei Liu, David M Slifer: Reduction of flake-like aggregation in nanoparticulate active agent compositions. Alkermes Pharma Ireland, Foley & Lardner, May 22, 2018: US09974746

This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. ...


6
Niels P Ryde, Peter Snyder, Wei Liu, David M Slifer: Reduction of flake-like aggregation in nanoparticulate active agent compositions. Alkermes Pharma Ireland, Foley & Lardner, May 22, 2018: US09974747

This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. ...


7
Niels P Ryde, Peter Snyder, Wei Liu, David M Slifer: Reduction of flake-like aggregation in nanoparticulate active agent compositions. Alkermes Pharma Ireland, Foley & Lardner, May 22, 2018: US09974748

This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. ...


8
Liversidge Gary G, Liversidge Elaine M, Sarpotdar Pramod P: Nanoparticules anticancereuses a surface modifiee, Surface modified anticancer nanoparticles. Sterling Winthrop, Elan Pharma International, FETHERSTONHAUGH & CO, October 14, 2003: CA2098242

Dispersible particles consisting essentially of acrystalline anticancer agent having a surface modifieradsorbed on the surface thereof in an amount sufficient tomaintain an effective average particle size of less thanabout 1000 nm. Anticancer compositions comprising theparticles exhibit reduced toxi ...


9
Pramod P Sarpotdar, Elaine Livrsidge, Gary G Liversidge: Surface modified anticancer nanoparticles. Sterling Winthrop, TIAN MINGSHENG LUO CAIXI, March 30, 1994: CN93108050

The invention discloses dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 100 nm. Anticancer compositions comprising the pa ...


10